Ramez Eskander (@rne_md) 's Twitter Profile
Ramez Eskander

@rne_md

Gyn Oncologist with passion for excellent patient care, clinical trials and drug development. Associate professor @UCSD_OBGYN, views = own

ID: 925776861853921280

calendar_today01-11-2017 17:29:38

179 Tweet

682 Followers

172 Following

Ramez Eskander (@rne_md) 's Twitter Profile Photo

SHAPE trial results presented at #ASCO2023 supporting safety of less radical surgery in appropriately selected early stage cervical cancer patients with improved quality of life. Less is more.

SHAPE trial results presented at #ASCO2023 supporting safety of less radical surgery in appropriately selected early stage cervical cancer patients with improved quality of life. Less is more.
Shannon Westin, MD, MPH, FASCO (@shannonwestin) 's Twitter Profile Photo

🙌 Really exciting data presented by Dr. Moore on DB-1303- this #HER2 #AntibodyDrugConjugate demonstrated 44% response rate in heavily pre-treated patients! #ASCO23 #gyncsm

🙌 Really exciting data presented by Dr. Moore on DB-1303- this #HER2 #AntibodyDrugConjugate demonstrated 44% response rate in heavily pre-treated patients! #ASCO23 #gyncsm
Ramez Eskander (@rne_md) 's Twitter Profile Photo

#ASCO2023 final OS of Keynote-826 confirming survival advantage of pembrolizumab in persistent,recurrent, metastatic cervical cancer. A one year improvement in median OS…and the tail of the curve is provocative!

#ASCO2023  final OS of Keynote-826 confirming survival advantage of pembrolizumab in persistent,recurrent, metastatic cervical cancer. A one year improvement in median OS…and the tail of the curve is provocative!
Ramez Eskander (@rne_md) 's Twitter Profile Photo

Neoadjuvant dual ICB safe and appears to augment CD8/FOXP3+ ratio and to increase “HOT” scores. As we know, appropriately sequencing IO in LACC may be critical to ensure success. #ASCO2023

Neoadjuvant dual ICB safe and appears to augment CD8/FOXP3+ ratio and to increase “HOT” scores.  As we know, appropriately sequencing IO in LACC may be critical to ensure success. #ASCO2023
Annie Ellis (@stigetta) 's Twitter Profile Photo

Ana Oaknin: Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), safety & efficacy in a broad distribution of FolRα exp in pts w/ recurrent ovarian cancer (OC): Update of STRO-002-GM1 P 1 dose expansion cohort. #ASCO23 #gyncsm

Ana Oaknin: Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), safety & efficacy in a broad distribution of FolRα exp in pts w/ recurrent ovarian cancer (OC): Update of STRO-002-GM1 P 1 dose expansion cohort. #ASCO23 #gyncsm
Wendel Naumann (@wendel_naumann) 's Twitter Profile Photo

A sad day for the medical world. He saved thousands from dying from cervical cancer! Harald zur Hausen, Nobelist who found cause of cervical cancer, dies at 87 beckershospitalreview.com/oncology/haral…

Angeles Secord (@angelessecord) 's Twitter Profile Photo

Mario M. Leitao, Jr Great shout out Mario for Ginger J. Gardner she’s amazing and doing a wonderful job, spreading awareness about GYN cancer and improving funding for research #move4her

Amanda Nickles Fader, MD (@amandanfader) 's Twitter Profile Photo

The must-read The Lancet Commission report on Women, Power, and Cancer just released 🔥. An outstanding virtual forum w/ The Lancet, World Health Organization (WHO) & National Cancer Institute is happening now. Key findings listed below 👇in the chat. SGO @https://www.thelancet.com/commissions/women-power-and-cancer

UC San Diego Health Moores Cancer Center (@ucsdcancer) 's Twitter Profile Photo

After being diagnosed with #ProstateCancer, Mike Haynes has become a strong advocate for prostate cancer screening through the NFL’s Crucial Catch Program To learn about comprehensive, personalized prostate cancer care UC San Diego Health, visit health.ucsd.edu/prostate

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🎄🚨 Exciting Christmas Eve news! Just published in Annals of Oncology ESMO - Eur. Oncology 🎁 Delighted to unwrap our small #PrecisionMedicine present to the scientific & clinical trial community - our latest publication, "Liquid Biopsy Response Evaluation Criteria in Solid Tumors

🎄🚨 Exciting Christmas Eve news! Just published in <a href="/Annals_Oncology/">Annals of Oncology</a> <a href="/myESMO/">ESMO - Eur. Oncology</a> 
🎁 Delighted to unwrap our small #PrecisionMedicine present to the scientific &amp; clinical trial community - our latest publication, "Liquid Biopsy Response Evaluation Criteria in Solid Tumors
The GOG Foundation Inc. (@gog) 's Twitter Profile Photo

Congratulations to the Top 50 Recruting Sites! Thank you for your commitment and dedication to the GOG and NRG and to accrual on clinical trials. #GOGF #GOGPartners #clinicaltrials #gynecologiconcology

ASCO (@asco) 's Twitter Profile Photo

Our members are sending a clear message to policymakers: cancer #drugshortages have gone on for too long, and we need solutions now. Add your voice and sign our Open Letter: brnw.ch/21wITOO #ASCOAdvocacy

UCSD Moores Cancer Center- Clinical Trials Office (@ucsdcancercto) 's Twitter Profile Photo

Join us at Moores Cancer Center for Clinical Trials Patient Appreciation Day! Explore clinical trials, hear inspiring survivor stories, & connect with fellow patients and caregivers. Don't miss this FREE event and RSVP: bit.ly/4aQi73o #ClinicalTrials #PatientAppreciation

Join us at Moores Cancer Center for Clinical Trials Patient Appreciation Day! Explore clinical trials, hear inspiring survivor stories, &amp; connect with fellow patients and caregivers. Don't miss this FREE event and RSVP: bit.ly/4aQi73o #ClinicalTrials #PatientAppreciation
UCSD Health Moores Cancer Center COE (@ucsdcancer_coe) 's Twitter Profile Photo

📢📢¡Atención! Our amazing partners SDCPC are launching their first Regional Collaborative meetings this week. We'll be with them each step of the way to talk about our exciting Promotores Advisory Board opportunity. Sign up here & please share: docs.google.com/forms/d/e/1FAI…

📢📢¡Atención! Our amazing partners <a href="/sdcpromotores/">SDCPC</a> are launching their first Regional Collaborative meetings this week. We'll be with them each step of the way to talk about our exciting Promotores Advisory Board opportunity. Sign up here &amp; please share: docs.google.com/forms/d/e/1FAI…